subcutaneous injection

Peptide Bioavailability: Delivery Methods

Desmopressin achieves 85% absolute bioavailability via subcutaneous injection but only 0.16% via intranasal spray—a gap that illustrates how peptide bioavailability depends as much on delivery route as on molecular structure.